New York State Common Retirement Fund Coherus Bio Sciences, Inc. Transaction History

New York State Common Retirement Fund

  • $74.9 Billion
  • Q3 2025

A detailed history of New York State Common Retirement Fund transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 20,593 shares of CHRS stock, worth $24,505. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,593
Previous 20,593 -0.0%
Holding current value
$24,505
Previous $15,000 120.0%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Oct 08, 2025
SELL
$0.67 - $1.71 $60,691 - $154,900
-90,585 Reduced 81.48%
20,593 $28,000
Q4 2024

Jan 31, 2025
SELL
$0.67 - $1.71 $60,691 - $154,900
-90,585 Reduced 81.48%
20,593 $28,000
Q3 2024

Oct 08, 2025
BUY
$0.99 - $1.8 $89,679 - $163,053
90,585 Added 439.88%
111,178 $115,000
Q2 2024

Oct 08, 2025
BUY
$1.58 - $2.51 $143,124 - $227,368
90,585 Added 439.88%
111,178 $192,000
Q2 2024

Jul 31, 2024
BUY
$1.58 - $2.51 $112 - $178
71 Added 0.06%
111,178 $192,000
Q1 2024

Oct 08, 2025
BUY
$2.02 - $3.14 $182,838 - $284,213
90,514 Added 439.54%
111,107 $265,000
Q1 2024

May 07, 2024
SELL
$2.02 - $3.14 $208 - $323
-103 Reduced 0.09%
111,107 $266,000
Q4 2023

Oct 08, 2025
BUY
$1.59 - $3.85 $144,081 - $348,875
90,617 Added 440.04%
111,210 $370,000
Q4 2023

Feb 01, 2024
SELL
$1.59 - $3.85 $200 - $485
-126 Reduced 0.11%
111,210 $370,000
Q3 2023

Oct 08, 2025
BUY
$3.74 - $5.45 $339,378 - $494,549
90,743 Added 440.65%
111,336 $416,000
Q3 2023

Nov 07, 2023
SELL
$3.74 - $5.45 $1,193 - $1,738
-319 Reduced 0.29%
111,336 $416,000
Q2 2023

Oct 08, 2025
BUY
$3.79 - $8.3 $345,124 - $755,814
91,062 Added 442.2%
111,655 $476,000
Q2 2023

Aug 07, 2023
BUY
$3.79 - $8.3 $12,999 - $28,469
3,430 Added 3.17%
111,655 $477,000
Q1 2023

Oct 08, 2025
BUY
$5.89 - $10.52 $36,423 - $65,055
6,184 Added 6.06%
108,225 $740,000
Q1 2023

May 02, 2023
BUY
$5.89 - $10.52 $36,423 - $65,055
6,184 Added 6.06%
108,225 $740,000
Q4 2022

Oct 08, 2025
BUY
$5.69 - $10.07 $463,439 - $820,181
81,448 Added 395.51%
102,041 $808,000
Q3 2022

Nov 08, 2022
SELL
$7.17 - $13.87 $249,931 - $483,480
-34,858 Reduced 25.46%
102,041 $981,000
Q2 2022

Aug 04, 2022
SELL
$5.86 - $13.23 $51,550 - $116,384
-8,797 Reduced 6.04%
136,899 $991,000
Q1 2022

May 05, 2022
SELL
$10.92 - $16.41 $254,501 - $382,451
-23,306 Reduced 13.79%
145,696 $1.88 Million
Q4 2021

Feb 02, 2022
BUY
$15.81 - $18.99 $82,986 - $99,678
5,249 Added 3.21%
169,002 $2.7 Million
Q3 2021

Nov 02, 2021
BUY
$12.68 - $17.79 $493,746 - $692,724
38,939 Added 31.2%
163,753 $2.63 Million
Q2 2021

Aug 02, 2021
BUY
$12.95 - $15.41 $186,298 - $221,688
14,386 Added 13.03%
124,814 $1.73 Million
Q1 2021

May 11, 2021
BUY
$14.42 - $21.39 $327,045 - $485,125
22,680 Added 25.85%
110,428 $1.61 Million
Q4 2020

Feb 08, 2021
SELL
$16.56 - $18.94 $422,279 - $482,970
-25,500 Reduced 22.52%
87,748 $1.53 Million
Q3 2020

Nov 05, 2020
BUY
$17.41 - $19.89 $408,630 - $466,838
23,471 Added 26.14%
113,248 $2.08 Million
Q2 2020

Aug 07, 2020
BUY
$14.43 - $19.16 $33,607 - $44,623
2,329 Added 2.66%
89,777 $1.6 Million
Q1 2020

May 06, 2020
BUY
$11.67 - $22.53 $259,109 - $500,233
22,203 Added 34.03%
87,448 $1.42 Million
Q4 2019

Feb 05, 2020
BUY
$16.33 - $21.37 $30,128 - $39,427
1,845 Added 2.91%
65,245 $1.18 Million
Q2 2019

Aug 09, 2019
BUY
$13.1 - $22.1 $182,090 - $307,190
13,900 Added 28.08%
63,400 $1.4 Million
Q4 2018

Feb 08, 2019
SELL
$8.65 - $16.28 $22,490 - $42,328
-2,600 Reduced 4.99%
49,500 $448,000
Q2 2018

Aug 10, 2018
BUY
$10.25 - $17.45 $108,650 - $184,970
10,600 Added 25.54%
52,100 $729,000
Q1 2018

May 10, 2018
SELL
$9.1 - $13.7 $19,110 - $28,770
-2,100 Reduced 4.82%
41,500 $459,000
Q2 2017

Aug 11, 2017
BUY
N/A
43,600
43,600 $626,000

Others Institutions Holding CHRS

# of Institutions
125
Shares Held
54.7M
Call Options Held
291K
Put Options Held
120K
View Full List

About Coherus BioSciences, Inc.

CHRS Quotes by TradingView
  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $92.5M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email